Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Generate Biomedicines, Inc. | 13,702,224 | reported | 02 Mar 2026 | tx 19+37,686,220−50,080,163 |
| Omega Therapeutics, Inc. | 0 | reported | 03 Aug 2021 | tx 20+23,705,210−85,108,565 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 12,723,940 | — | |
| 02 Mar 2026 | PURCHASE | Generate Biomedicines, Inc. | 1,562,500 | 16.00 USD | first after silence |
| 02 Mar 2026 | PURCHASE | Generate Biomedicines, Inc. | 1,562,500 | 16.00 USD | |
| 02 Mar 2026 | PURCHASE | Generate Biomedicines, Inc. | 1,562,500 | 16.00 USD | |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,777,752 | — | |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,777,752 | — | |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 987,491 | — | |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 13,702,224 | — | |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,953,586 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,109,704 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,531,644 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 1,265,822 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 2,109,704 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Generate Biomedicines, Inc. | 29,561 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 18,483,785 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 17,016,215 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 1,500,000 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 843,881 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 1,265,822 | 0.00 USD | deriv |
| 03 Aug 2021 | CONVERSION | Omega Therapeutics, Inc. | 1,088,470 | — | |
| 03 Aug 2021 | CONVERSION | Omega Therapeutics, Inc. | 5,896,386 | — | |
| 03 Aug 2021 | CONVERSION | Omega Therapeutics, Inc. | 8,396,825 | — | |
| 03 Aug 2021 | PURCHASE | Omega Therapeutics, Inc. | 220,588 | 17.00 USD | |
| 03 Aug 2021 | PURCHASE | Omega Therapeutics, Inc. | 294,117 | 17.00 USD | |
| 03 Aug 2021 | CONVERSION | Omega Therapeutics, Inc. | 4,852,943 | — |
1 purchase reported after at least 12 months of silence — most recent on 02 Mar 2026.